New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For SPPI From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
September 26, 2014
17:10 EDTSPPISpectrum reports 16.66% stake in CASI Pharmaceuticals
Spectrum entered into the investment agreements in order to acquire shares of common stock of CASI Pharmaceuticals for investment purposes with the goal of increasing the value of the company as a result of, among other things, CASI's development and commercialization of Zevalin and captisol-enabled melphalan in Greater China.
September 22, 2014
11:48 EDTSPPISpectrum management to meet with Roth Capital
Subscribe for More Information
September 18, 2014
07:07 EDTSPPISpectrum out-licenses rights for Greater China to CASI for three drugs
Subscribe for More Information
07:05 EDTSPPISpectrum out-licenses rights for Greater China to CASI for three drugs
Subscribe for More Information
September 16, 2014
07:02 EDTSPPISpectrum issued new patent for Beleodaq for injection
Spectrum Pharmaceuticals announced that the United States Patent and Trademark Office has issued U.S. Patent No. 8835501, which covers Beleodaq for Injection on September 16, 2014 with patent term adjustment from May 2026 to October 2027. In addition to the existing patent, covering the chemical entity of Beleodaq, this new patent covers the formulation of the product, strengthening and expanding significantly its industrial property protection.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use